maltose123 personal page - To The Moon

maltose123

maltose123

No personal profile

1Follow

0Followers

0Topic

0Badge

2021-03-16

hjjh

Sorry, the original content has been removed

2021-03-11

ooo

Sorry, the original content has been removed

2021-03-09

hi

Sorry, the original content has been removed

2021-03-09

mdndhd

Novartis, Molecular Partners report positive early-stage results of COVID-19 antiviral therapy, ensovibep

2021-03-09

likpoo

Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3578010145980988","uuid":"3578010145980988","gmtCreate":1614916122097,"gmtModify":1614917288879,"name":"maltose123","pinyin":"maltose123","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":1,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.40%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":325163694,"gmtCreate":1615876909718,"gmtModify":1704787799615,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"hjjh","listText":"hjjh","text":"hjjh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325163694","repostId":"1117628563","repostType":4,"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321633356,"gmtCreate":1615427447575,"gmtModify":1704782618552,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"ooo","listText":"ooo","text":"ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321633356","repostId":"2118860390","repostType":4,"isVote":1,"tweetType":1,"viewCount":46,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329448803,"gmtCreate":1615274765702,"gmtModify":1704780425946,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329448803","repostId":"1120347289","repostType":4,"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329457469,"gmtCreate":1615274030751,"gmtModify":1704780419133,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"&nbsp;mdndhd","listText":"&nbsp;mdndhd","text":"mdndhd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329457469","repostId":"1168910610","repostType":4,"repost":{"id":"1168910610","kind":"news","pubTimestamp":1615272511,"share":"https://ttm.financial/m/news/1168910610?lang=&edition=fundamental","pubTime":"2021-03-09 14:48","market":"us","language":"en","title":"Novartis, Molecular Partners report positive early-stage results of COVID-19 antiviral therapy, ensovibep","url":"https://stock-news.laohu8.com/highlight/detail?id=1168910610","media":"seekingalpha","summary":"Molecular Partners(OTCPK:MLLCF)and itscollaboratorNovartis(NYSE:NVS)announced initial results from t","content":"<p>Molecular Partners(OTCPK:MLLCF)and itscollaboratorNovartis(NYSE:NVS)announced initial results from their ongoing phase 1 study of first tri-specificCOVID-19 antiviral treatment, ensovibep (MP0420), in healthy volunteers.</p><p>Healthy volunteers were randomized 3:1 to receive ensovibep or placebo, respectively.</p><p>Two dosing cohorts with 8 patients per dose cohort have been fully enrolled and received a single infusion of 3mg or 9mg per kilogram body weight.</p><p>In each of these cohorts, ensovibep was seen to be safe and well tolerated, with no significant adverse events reported.</p><p>Preliminary results showed extended exposure of the DARPin candidate in serum, with a half-life of 2-3 weeks.</p><p>These data support advanced plans for additional clinical work in positively diagnosed patients.</p><p>The companies looks forward to initiate phase 2/3 global registration study, early in Q2.</p><p>Per protocol, a third cohort at a 20mg per kilogram dose level has been planned.</p><p>In October 2020, Molecular Partners and Novartis collaborated to developtwo DARPin therapies for COVID-19.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novartis, Molecular Partners report positive early-stage results of COVID-19 antiviral therapy, ensovibep</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovartis, Molecular Partners report positive early-stage results of COVID-19 antiviral therapy, ensovibep\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-09 14:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3670544-novartis-molecular-partners-report-positive-early-stage-results-of-covid-19-antiviral-therapy-ensovibep><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Molecular Partners(OTCPK:MLLCF)and itscollaboratorNovartis(NYSE:NVS)announced initial results from their ongoing phase 1 study of first tri-specificCOVID-19 antiviral treatment, ensovibep (MP0420), in...</p>\n\n<a href=\"https://seekingalpha.com/news/3670544-novartis-molecular-partners-report-positive-early-stage-results-of-covid-19-antiviral-therapy-ensovibep\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MLLCF":"Molecular Partners AG","NVS":"诺华"},"source_url":"https://seekingalpha.com/news/3670544-novartis-molecular-partners-report-positive-early-stage-results-of-covid-19-antiviral-therapy-ensovibep","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1168910610","content_text":"Molecular Partners(OTCPK:MLLCF)and itscollaboratorNovartis(NYSE:NVS)announced initial results from their ongoing phase 1 study of first tri-specificCOVID-19 antiviral treatment, ensovibep (MP0420), in healthy volunteers.Healthy volunteers were randomized 3:1 to receive ensovibep or placebo, respectively.Two dosing cohorts with 8 patients per dose cohort have been fully enrolled and received a single infusion of 3mg or 9mg per kilogram body weight.In each of these cohorts, ensovibep was seen to be safe and well tolerated, with no significant adverse events reported.Preliminary results showed extended exposure of the DARPin candidate in serum, with a half-life of 2-3 weeks.These data support advanced plans for additional clinical work in positively diagnosed patients.The companies looks forward to initiate phase 2/3 global registration study, early in Q2.Per protocol, a third cohort at a 20mg per kilogram dose level has been planned.In October 2020, Molecular Partners and Novartis collaborated to developtwo DARPin therapies for COVID-19.","news_type":1},"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329457280,"gmtCreate":1615274014440,"gmtModify":1704780419455,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"likpoo","listText":"likpoo","text":"likpoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329457280","repostId":"2118923226","repostType":4,"repost":{"id":"2118923226","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615271378,"share":"https://ttm.financial/m/news/2118923226?lang=&edition=fundamental","pubTime":"2021-03-09 14:29","market":"us","language":"en","title":"Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study","url":"https://stock-news.laohu8.com/highlight/detail?id=2118923226","media":"Reuters","summary":"NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutr","content":"<p>NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.</p>\n<p>Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.</p>\n<p>The scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.</p>\n<p>The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.</p>\n<p>In previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.</p>\n<p>Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-09 14:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.</p>\n<p>Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.</p>\n<p>The scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.</p>\n<p>The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.</p>\n<p>In previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.</p>\n<p>Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118923226","content_text":"NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.\nBlood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.\nThe scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.\nThe spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.\nIn previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.\nPfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.","news_type":1},"isVote":1,"tweetType":1,"viewCount":188,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":325163694,"gmtCreate":1615876909718,"gmtModify":1704787799615,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"hjjh","listText":"hjjh","text":"hjjh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325163694","repostId":"1117628563","repostType":4,"repost":{"id":"1117628563","kind":"news","pubTimestamp":1615875641,"share":"https://ttm.financial/m/news/1117628563?lang=&edition=fundamental","pubTime":"2021-03-16 14:20","market":"us","language":"en","title":"Netflix May Crack Down on Password Sharing. Here’s What It Means for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1117628563","media":"Barrons","summary":"Netflix stock rose on Monday as analysts on both sides of the Bull-Bear debate weighed in on potenti","content":"<p>Netflix&nbsp;stock rose on Monday as analysts on both sides of the Bull-Bear debate weighed in on potential plans to crack down on password sharing.</p>\n<p>Benchmark analyst Matthew Harrigan, who rates the stock a Sell, lowered his price target to $472 from $485. Harriganrefers to reportsthat certain users received messages Friday asking them to make their own account if they don’t live with the actual subscriber.</p>\n<p>“This test is designed to help ensure that people using Netflix accounts are authorized to do so,” a spokesperson&nbsp;told MarketWatch.</p>\n<p>Harrigan argues any such crackdown will require finesse. He refers to estimates from research firm Magid that about 33% of Netflix members share passwords but argues that those benefiting from password sharing may be more casual or economically sensitive users.</p>\n<p>“Although a crackdown on password sharing could emerge as an at least marginal long-term positive, we believe that it somewhat dampens pricing power even as competition from Disney+ and others mounts,” he writes.</p>\n<p>Harrigan added that Netflix stock’s appealhas been diminished&nbsp;by rising competition from Disney+ and the rollout of Covid-19 vaccinations. He estimates Netflix will hit 313 million global members in 2024, not far ahead of&nbsp;Walt Disney’s(DIS) global target of&nbsp;230 million to 260 million Disney+ subscribers&nbsp;during fiscal 2024.</p>\n<p>“Disney will almost certainly emerge as the overall global streaming leader if ESPN+ and Hulu are aggregated as well,” he writes. “Disney+ achieved 100M global customers on its platforms earlier this month only 16 months after launch—which had taken Netflix a decade to achieve.”</p>\n<p>On the side of the debate is BMO Capital Markets analyst Daniel Salmon, who has an Outperform rating and a $700 price target. He titled his late-Sunday night note, “The Password Is: StillTopPick42021.”</p>\n<p>He argues that Netflix has always had the option to clamp down on password sharing in its back pocket, and believes such a move can drive gross subscriber additions and help member growth as the company approaches tough year-over-year comparisons from the 2020 shutdowns. The move could drive upside to consensus expectations for subscribers during the fiscal first quarter, according to Salmon.</p>\n<p>Netflix stock rose 0.4% to $520.25 on Monday, while the&nbsp;S&amp;P 500 index&nbsp;was up about 0.7%. There are 40 analysts covering the stock listed by FactSet. Of that group, 27 analysts have Buy or equivalent ratings, while four have Sell or equivalent ratings. The rest are in between. But the mean price target for the stock is $626.88, according to FactSet, which implies about 20% upside from recent levels.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix May Crack Down on Password Sharing. Here’s What It Means for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix May Crack Down on Password Sharing. Here’s What It Means for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 14:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/netflix-may-crack-down-on-password-sharing-what-it-means-for-the-stock-51615849524?mod=RTA><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Netflix stock rose on Monday as analysts on both sides of the Bull-Bear debate weighed in on potential plans to crack down on password sharing.\nBenchmark analyst Matthew Harrigan, who rates the stock ...</p>\n\n<a href=\"https://www.barrons.com/articles/netflix-may-crack-down-on-password-sharing-what-it-means-for-the-stock-51615849524?mod=RTA\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞"},"source_url":"https://www.barrons.com/articles/netflix-may-crack-down-on-password-sharing-what-it-means-for-the-stock-51615849524?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117628563","content_text":"Netflix stock rose on Monday as analysts on both sides of the Bull-Bear debate weighed in on potential plans to crack down on password sharing.\nBenchmark analyst Matthew Harrigan, who rates the stock a Sell, lowered his price target to $472 from $485. Harriganrefers to reportsthat certain users received messages Friday asking them to make their own account if they don’t live with the actual subscriber.\n“This test is designed to help ensure that people using Netflix accounts are authorized to do so,” a spokesperson told MarketWatch.\nHarrigan argues any such crackdown will require finesse. He refers to estimates from research firm Magid that about 33% of Netflix members share passwords but argues that those benefiting from password sharing may be more casual or economically sensitive users.\n“Although a crackdown on password sharing could emerge as an at least marginal long-term positive, we believe that it somewhat dampens pricing power even as competition from Disney+ and others mounts,” he writes.\nHarrigan added that Netflix stock’s appealhas been diminished by rising competition from Disney+ and the rollout of Covid-19 vaccinations. He estimates Netflix will hit 313 million global members in 2024, not far ahead of Walt Disney’s(DIS) global target of 230 million to 260 million Disney+ subscribers during fiscal 2024.\n“Disney will almost certainly emerge as the overall global streaming leader if ESPN+ and Hulu are aggregated as well,” he writes. “Disney+ achieved 100M global customers on its platforms earlier this month only 16 months after launch—which had taken Netflix a decade to achieve.”\nOn the side of the debate is BMO Capital Markets analyst Daniel Salmon, who has an Outperform rating and a $700 price target. He titled his late-Sunday night note, “The Password Is: StillTopPick42021.”\nHe argues that Netflix has always had the option to clamp down on password sharing in its back pocket, and believes such a move can drive gross subscriber additions and help member growth as the company approaches tough year-over-year comparisons from the 2020 shutdowns. The move could drive upside to consensus expectations for subscribers during the fiscal first quarter, according to Salmon.\nNetflix stock rose 0.4% to $520.25 on Monday, while the S&P 500 index was up about 0.7%. There are 40 analysts covering the stock listed by FactSet. Of that group, 27 analysts have Buy or equivalent ratings, while four have Sell or equivalent ratings. The rest are in between. But the mean price target for the stock is $626.88, according to FactSet, which implies about 20% upside from recent levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321633356,"gmtCreate":1615427447575,"gmtModify":1704782618552,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"ooo","listText":"ooo","text":"ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321633356","repostId":"2118860390","repostType":4,"repost":{"id":"2118860390","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1615413960,"share":"https://ttm.financial/m/news/2118860390?lang=&edition=fundamental","pubTime":"2021-03-11 06:06","market":"hk","language":"en","title":"Dow ends above 32,000 milestone for first time. Here's how it got there","url":"https://stock-news.laohu8.com/highlight/detail?id=2118860390","media":"Dow Jones","summary":"Goldman shares are biggest contributor to the Dow's latest 1,000-point climb.\n\nThe Dow Jones Industr","content":"<blockquote>\n Goldman shares are biggest contributor to the Dow's latest 1,000-point climb.\n</blockquote>\n<p>The Dow Jones Industrial Average on Wednesday closed above the psychologically significant 32,000 level, registering a milestone during a turbulent period for the stock market as the economic recovery from the pandemic takes shape.</p>\n<p>The 30-stock index closed at 32,297.02, as the Nasdaq Composite finished in negative territory, still wallowing in correction from its Feb. 12 record. But the Dow traversed 42 trading days before clearing its latest 1,000-point milestone, marking the quickest such move since it climbed from 30,000 to 31,000 on Jan. 6 .</p>\n<p>The rally for the blue-chip index comes as economic data suggests that worries about out-of-control inflation perhaps have been overblow, at least in the short-term, helping to power a rally in those stocks that might perform best against the backdrop of an improved business environment.</p>\n<p>On top of that, the House, in a 220-211 vote, passed a $1.9 trillion coronavirus-relief bill are brightening the prospects for a strong rebound from the public health disaster.</p>\n<p>Against that backdrop, the Dow has managed to climb despite a bout of turbulence over the past several weeks, and growing worries about stock-market valuations.</p>\n<p>A rise in benchmark bond yields also has propelled a rotation out of highflying technology and growth-oriented stocks and into those considered more cyclical in nature like energy, industrials and financials, which should perform best as the economy improves.</p>\n<p>Specifically, Goldman Sachs <a href=\"https://laohu8.com/S/GS\">$(GS)$</a> was the biggest contributor to the Dow's 1,000-point climb, ringing up over 330 points, according to Dow Jones Market Data. The Boeing Co. <a href=\"https://laohu8.com/S/BA\">$(BA)$</a>, adding 214 points, was the second-best contributor for the price-oriented index.</p>\n<p>Here's a complete list of the leaders and the laggards:</p>\n<table>\n <tbody>\n  <tr>\n   <td>AMGNTicker</td>\n   <td>Point Contribution</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs</td>\n   <td>331.41</td>\n  </tr>\n  <tr>\n   <td>Boeing</td>\n   <td>214.69</td>\n  </tr>\n  <tr>\n   <td>Caterpillar CAT</td>\n   <td>176.53</td>\n  </tr>\n  <tr>\n   <td>American <a href=\"https://laohu8.com/S/EXPR\">Express</a> AXP</td>\n   <td>165.08</td>\n  </tr>\n  <tr>\n   <td>Chevron Corp. CVX</td>\n   <td>139.16</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co. JPM</td>\n   <td>126.72</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co. DIS</td>\n   <td>108.43</td>\n  </tr>\n  <tr>\n   <td>Travelers Cos. Inc. TRV</td>\n   <td>107.31</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MMM\">3M</a> MMM</td>\n   <td>97.31</td>\n  </tr>\n  <tr>\n   <td>Microsoft MSFT</td>\n   <td>92.97</td>\n  </tr>\n  <tr>\n   <td>Intel Corp. INTC</td>\n   <td>66.19</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/V\">Visa</a> V</td>\n   <td>61.58</td>\n  </tr>\n  <tr>\n   <td>Dow Inc. DOW</td>\n   <td>36.71</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc.</td>\n   <td>34.61</td>\n  </tr>\n  <tr>\n   <td>Cisco CSCO</td>\n   <td>21.91</td>\n  </tr>\n  <tr>\n   <td>Coca-Cola Co. KO</td>\n   <td>9.74</td>\n  </tr>\n  <tr>\n   <td>McDonald's Corp. MCD</td>\n   <td>8.75</td>\n  </tr>\n  <tr>\n   <td>Honeywell HON</td>\n   <td>1.97</td>\n  </tr>\n  <tr>\n   <td>Home Depot HD</td>\n   <td>-0.13</td>\n  </tr>\n  <tr>\n   <td>International Business Machines <a href=\"https://laohu8.com/S/IBM\">IBM</a></td>\n   <td>-7.37</td>\n  </tr>\n  <tr>\n   <td>Johnson &amp; Johnson JNJ</td>\n   <td>-8.03</td>\n  </tr>\n  <tr>\n   <td>Verizon Communications VZ</td>\n   <td>-9.54</td>\n  </tr>\n  <tr>\n   <td>Amgen AMGN</td>\n   <td>-26.21</td>\n  </tr>\n  <tr>\n   <td>salesforce.com CRM</td>\n   <td>-39.61</td>\n  </tr>\n  <tr>\n   <td>Nike NKE</td>\n   <td>-48.43</td>\n  </tr>\n  <tr>\n   <td>Merck MRK</td>\n   <td>-60.93</td>\n  </tr>\n  <tr>\n   <td>Apple AAPL</td>\n   <td>-71.98</td>\n  </tr>\n  <tr>\n   <td>Procter &amp; Gamble PG</td>\n   <td>-75.73</td>\n  </tr>\n  <tr>\n   <td>Walmart WMT</td>\n   <td>-95.21</td>\n  </tr>\n  <tr>\n   <td>UnitedHealth Group Inc. UNH</td>\n   <td>-101.52</td>\n  </tr>\n  <tr>\n   <td></td>\n   <td>Source: Dow Jones Market Data</td>\n  </tr>\n </tbody>\n</table>\n<p>Also worth noting is that the higher the Dow rises, the smaller each 1,000-point move is in percentage terms, but individual investors have tended to pay close attention to the Dow when it carves out fresh milestones.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow ends above 32,000 milestone for first time. Here's how it got there</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow ends above 32,000 milestone for first time. Here's how it got there\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-11 06:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Goldman shares are biggest contributor to the Dow's latest 1,000-point climb.\n</blockquote>\n<p>The Dow Jones Industrial Average on Wednesday closed above the psychologically significant 32,000 level, registering a milestone during a turbulent period for the stock market as the economic recovery from the pandemic takes shape.</p>\n<p>The 30-stock index closed at 32,297.02, as the Nasdaq Composite finished in negative territory, still wallowing in correction from its Feb. 12 record. But the Dow traversed 42 trading days before clearing its latest 1,000-point milestone, marking the quickest such move since it climbed from 30,000 to 31,000 on Jan. 6 .</p>\n<p>The rally for the blue-chip index comes as economic data suggests that worries about out-of-control inflation perhaps have been overblow, at least in the short-term, helping to power a rally in those stocks that might perform best against the backdrop of an improved business environment.</p>\n<p>On top of that, the House, in a 220-211 vote, passed a $1.9 trillion coronavirus-relief bill are brightening the prospects for a strong rebound from the public health disaster.</p>\n<p>Against that backdrop, the Dow has managed to climb despite a bout of turbulence over the past several weeks, and growing worries about stock-market valuations.</p>\n<p>A rise in benchmark bond yields also has propelled a rotation out of highflying technology and growth-oriented stocks and into those considered more cyclical in nature like energy, industrials and financials, which should perform best as the economy improves.</p>\n<p>Specifically, Goldman Sachs <a href=\"https://laohu8.com/S/GS\">$(GS)$</a> was the biggest contributor to the Dow's 1,000-point climb, ringing up over 330 points, according to Dow Jones Market Data. The Boeing Co. <a href=\"https://laohu8.com/S/BA\">$(BA)$</a>, adding 214 points, was the second-best contributor for the price-oriented index.</p>\n<p>Here's a complete list of the leaders and the laggards:</p>\n<table>\n <tbody>\n  <tr>\n   <td>AMGNTicker</td>\n   <td>Point Contribution</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs</td>\n   <td>331.41</td>\n  </tr>\n  <tr>\n   <td>Boeing</td>\n   <td>214.69</td>\n  </tr>\n  <tr>\n   <td>Caterpillar CAT</td>\n   <td>176.53</td>\n  </tr>\n  <tr>\n   <td>American <a href=\"https://laohu8.com/S/EXPR\">Express</a> AXP</td>\n   <td>165.08</td>\n  </tr>\n  <tr>\n   <td>Chevron Corp. CVX</td>\n   <td>139.16</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co. JPM</td>\n   <td>126.72</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co. DIS</td>\n   <td>108.43</td>\n  </tr>\n  <tr>\n   <td>Travelers Cos. Inc. TRV</td>\n   <td>107.31</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MMM\">3M</a> MMM</td>\n   <td>97.31</td>\n  </tr>\n  <tr>\n   <td>Microsoft MSFT</td>\n   <td>92.97</td>\n  </tr>\n  <tr>\n   <td>Intel Corp. INTC</td>\n   <td>66.19</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/V\">Visa</a> V</td>\n   <td>61.58</td>\n  </tr>\n  <tr>\n   <td>Dow Inc. DOW</td>\n   <td>36.71</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc.</td>\n   <td>34.61</td>\n  </tr>\n  <tr>\n   <td>Cisco CSCO</td>\n   <td>21.91</td>\n  </tr>\n  <tr>\n   <td>Coca-Cola Co. KO</td>\n   <td>9.74</td>\n  </tr>\n  <tr>\n   <td>McDonald's Corp. MCD</td>\n   <td>8.75</td>\n  </tr>\n  <tr>\n   <td>Honeywell HON</td>\n   <td>1.97</td>\n  </tr>\n  <tr>\n   <td>Home Depot HD</td>\n   <td>-0.13</td>\n  </tr>\n  <tr>\n   <td>International Business Machines <a href=\"https://laohu8.com/S/IBM\">IBM</a></td>\n   <td>-7.37</td>\n  </tr>\n  <tr>\n   <td>Johnson &amp; Johnson JNJ</td>\n   <td>-8.03</td>\n  </tr>\n  <tr>\n   <td>Verizon Communications VZ</td>\n   <td>-9.54</td>\n  </tr>\n  <tr>\n   <td>Amgen AMGN</td>\n   <td>-26.21</td>\n  </tr>\n  <tr>\n   <td>salesforce.com CRM</td>\n   <td>-39.61</td>\n  </tr>\n  <tr>\n   <td>Nike NKE</td>\n   <td>-48.43</td>\n  </tr>\n  <tr>\n   <td>Merck MRK</td>\n   <td>-60.93</td>\n  </tr>\n  <tr>\n   <td>Apple AAPL</td>\n   <td>-71.98</td>\n  </tr>\n  <tr>\n   <td>Procter &amp; Gamble PG</td>\n   <td>-75.73</td>\n  </tr>\n  <tr>\n   <td>Walmart WMT</td>\n   <td>-95.21</td>\n  </tr>\n  <tr>\n   <td>UnitedHealth Group Inc. UNH</td>\n   <td>-101.52</td>\n  </tr>\n  <tr>\n   <td></td>\n   <td>Source: Dow Jones Market Data</td>\n  </tr>\n </tbody>\n</table>\n<p>Also worth noting is that the higher the Dow rises, the smaller each 1,000-point move is in percentage terms, but individual investors have tended to pay close attention to the Dow when it carves out fresh milestones.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","AAPL":"苹果","GS":"高盛","09086":"华夏纳指-U","BA":"波音","03086":"华夏纳指"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118860390","content_text":"Goldman shares are biggest contributor to the Dow's latest 1,000-point climb.\n\nThe Dow Jones Industrial Average on Wednesday closed above the psychologically significant 32,000 level, registering a milestone during a turbulent period for the stock market as the economic recovery from the pandemic takes shape.\nThe 30-stock index closed at 32,297.02, as the Nasdaq Composite finished in negative territory, still wallowing in correction from its Feb. 12 record. But the Dow traversed 42 trading days before clearing its latest 1,000-point milestone, marking the quickest such move since it climbed from 30,000 to 31,000 on Jan. 6 .\nThe rally for the blue-chip index comes as economic data suggests that worries about out-of-control inflation perhaps have been overblow, at least in the short-term, helping to power a rally in those stocks that might perform best against the backdrop of an improved business environment.\nOn top of that, the House, in a 220-211 vote, passed a $1.9 trillion coronavirus-relief bill are brightening the prospects for a strong rebound from the public health disaster.\nAgainst that backdrop, the Dow has managed to climb despite a bout of turbulence over the past several weeks, and growing worries about stock-market valuations.\nA rise in benchmark bond yields also has propelled a rotation out of highflying technology and growth-oriented stocks and into those considered more cyclical in nature like energy, industrials and financials, which should perform best as the economy improves.\nSpecifically, Goldman Sachs $(GS)$ was the biggest contributor to the Dow's 1,000-point climb, ringing up over 330 points, according to Dow Jones Market Data. The Boeing Co. $(BA)$, adding 214 points, was the second-best contributor for the price-oriented index.\nHere's a complete list of the leaders and the laggards:\n\n\n\nAMGNTicker\nPoint Contribution\n\n\nGoldman Sachs\n331.41\n\n\nBoeing\n214.69\n\n\nCaterpillar CAT\n176.53\n\n\nAmerican Express AXP\n165.08\n\n\nChevron Corp. CVX\n139.16\n\n\nJPMorgan Chase & Co. JPM\n126.72\n\n\nWalt Disney Co. DIS\n108.43\n\n\nTravelers Cos. Inc. TRV\n107.31\n\n\n3M MMM\n97.31\n\n\nMicrosoft MSFT\n92.97\n\n\nIntel Corp. INTC\n66.19\n\n\nVisa V\n61.58\n\n\nDow Inc. DOW\n36.71\n\n\nWalgreens Boots Alliance Inc.\n34.61\n\n\nCisco CSCO\n21.91\n\n\nCoca-Cola Co. KO\n9.74\n\n\nMcDonald's Corp. MCD\n8.75\n\n\nHoneywell HON\n1.97\n\n\nHome Depot HD\n-0.13\n\n\nInternational Business Machines IBM\n-7.37\n\n\nJohnson & Johnson JNJ\n-8.03\n\n\nVerizon Communications VZ\n-9.54\n\n\nAmgen AMGN\n-26.21\n\n\nsalesforce.com CRM\n-39.61\n\n\nNike NKE\n-48.43\n\n\nMerck MRK\n-60.93\n\n\nApple AAPL\n-71.98\n\n\nProcter & Gamble PG\n-75.73\n\n\nWalmart WMT\n-95.21\n\n\nUnitedHealth Group Inc. UNH\n-101.52\n\n\n\nSource: Dow Jones Market Data\n\n\n\nAlso worth noting is that the higher the Dow rises, the smaller each 1,000-point move is in percentage terms, but individual investors have tended to pay close attention to the Dow when it carves out fresh milestones.","news_type":1},"isVote":1,"tweetType":1,"viewCount":46,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329448803,"gmtCreate":1615274765702,"gmtModify":1704780425946,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329448803","repostId":"1120347289","repostType":4,"repost":{"id":"1120347289","kind":"news","pubTimestamp":1615269642,"share":"https://ttm.financial/m/news/1120347289?lang=&edition=fundamental","pubTime":"2021-03-09 14:00","market":"fut","language":"en","title":"Bitcoin tops $1 trillion in value again as the cryptocurrency’s price jumps","url":"https://stock-news.laohu8.com/highlight/detail?id=1120347289","media":"cnbc","summary":"KEY POINTS\n\nBitcoin’s value briefly surpassed $1 trillion on Tuesday as the price of the cryptocurre","content":"<div>\n<p>KEY POINTS\n\nBitcoin’s value briefly surpassed $1 trillion on Tuesday as the price of the cryptocurrency jumped.\nThe digital coin’s price rose on Tuesday and its market capitalization went above $1 ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/09/bitcoin-btc-value-exceeds-1-trillion-for-second-time.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin tops $1 trillion in value again as the cryptocurrency’s price jumps</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin tops $1 trillion in value again as the cryptocurrency’s price jumps\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-09 14:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/09/bitcoin-btc-value-exceeds-1-trillion-for-second-time.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nBitcoin’s value briefly surpassed $1 trillion on Tuesday as the price of the cryptocurrency jumped.\nThe digital coin’s price rose on Tuesday and its market capitalization went above $1 ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/09/bitcoin-btc-value-exceeds-1-trillion-for-second-time.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust","PYPL":"PayPal","TSLA":"特斯拉"},"source_url":"https://www.cnbc.com/2021/03/09/bitcoin-btc-value-exceeds-1-trillion-for-second-time.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1120347289","content_text":"KEY POINTS\n\nBitcoin’s value briefly surpassed $1 trillion on Tuesday as the price of the cryptocurrency jumped.\nThe digital coin’s price rose on Tuesday and its market capitalization went above $1 trillion in mid-morning trade Singapore time.\nIt is only the second time that bitcoin’s value has surpassed a $1 trillion after hitting that milestone for the first time on Feb. 19.\n\nBitcoin’s value surpassed $1 trillion on Tuesday as the price of the cryptocurrency jumped.\nThe digital coin’s price rose on Tuesday and its market capitalization went above $1 trillion in mid-morning trade Singapore time, according to CoinDesk.\nBitcoin extended those gains hitting a 24-hour high of $54,348.57 in early afternoon Singapore time, around 7% higher than the same time a day before. Bitcoin has since pared some of those gains.\nIt is only the second time that bitcoin’s value has surpassed a $1 trillion after hitting that milestone for the first time on Feb. 19. Bitcoin’s market capitalization held above $1 trillion for a few days, before falling below that mark.\nEven though bitcoin is sitting off of its all-time-high of $58,332.36, it has seen a huge rally. The digital currency is up over 80% this year and 570% higher over the last 12 months.\nBitcoin’s rally has been attributed to several factors including participation from larger institutional investors and some notable purchases from corporations.Tesla,Square and Microstrategy area mong the companies that have purchased bitcoin.\nOn Sunday, a Chinese appmaker called Meitu said that it had purchased not only bitcoin, but another cryptocurrency called ether too.Ether, a cryptocurrency which runs on the Ethereum network, was trading at $1,836.73 at around 10:41 a.m. Singapore time, up nearly 7% from a day before, according to CoinDesk.\nCompanies are also making acquisitions in the cryptocurrency space.PayPal on Monday said it will buy cryptocurrency security firm Curv.\nProponents of bitcoin often liken it to “digital gold,” a hedge against inflation and potential “safe-haven” asset where investors can park their money in times of political or economic turmoil.\nSome argue that loose monetary policy such as low interest rates and asset purchases by central banks around the world erodes the value of fiat currencies like the U.S. dollar and bitcoin provides a better alternative to invest in.","news_type":1},"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329457469,"gmtCreate":1615274030751,"gmtModify":1704780419133,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"&nbsp;mdndhd","listText":"&nbsp;mdndhd","text":"mdndhd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329457469","repostId":"1168910610","repostType":4,"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329457280,"gmtCreate":1615274014440,"gmtModify":1704780419455,"author":{"id":"3578010145980988","authorId":"3578010145980988","name":"maltose123","avatar":"https://static.tigerbbs.com/071a4309a84b94aafc5b5d2c0fec025b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578010145980988","authorIdStr":"3578010145980988"},"themes":[],"htmlText":"likpoo","listText":"likpoo","text":"likpoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329457280","repostId":"2118923226","repostType":4,"repost":{"id":"2118923226","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615271378,"share":"https://ttm.financial/m/news/2118923226?lang=&edition=fundamental","pubTime":"2021-03-09 14:29","market":"us","language":"en","title":"Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study","url":"https://stock-news.laohu8.com/highlight/detail?id=2118923226","media":"Reuters","summary":"NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutr","content":"<p>NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.</p>\n<p>Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.</p>\n<p>The scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.</p>\n<p>The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.</p>\n<p>In previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.</p>\n<p>Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-09 14:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.</p>\n<p>Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.</p>\n<p>The scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.</p>\n<p>The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.</p>\n<p>In previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.</p>\n<p>Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118923226","content_text":"NEW YORK, March 8 (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.\nBlood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.\nThe scientists said the neutralizing ability was roughly equivalent the vaccine's effect on a previous less contagious version of the virus from last year.\nThe spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines.\nIn previously published studies, Pfizer had found that its vaccine neutralized other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.\nPfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response.","news_type":1},"isVote":1,"tweetType":1,"viewCount":188,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}